Needham Downgrades Kalvista Pharmaceuticals Inc (KALV) to Hold
Tweet
Share
E-mailGet Alerts KALV Hot Sheet
Price: $27.00 --0%
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 2 | New: 2
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 2 | New: 2
Join SI Premium – FREE
Needham analyst Serge Belanger downgraded Kalvista Pharmaceuticals Inc (NASDAQ: KALV) from Buy to Hold.
For an analyst ratings summary and ratings history on Kalvista Pharmaceuticals Inc click here. For more ratings news on Kalvista Pharmaceuticals Inc click here.
Shares of Kalvista Pharmaceuticals Inc closed at $26.67 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Downgrades BioMerieux (BIM:FP) (BMXMF) to Underweight
- Morgan Stanley Upgrades GEA Group AG (G1A:GR) (GEAGY) to Equalweight
- Morgan Stanley Upgrades QIAGEN NV (QIA:GR) (QGEN) to Overweight
Create E-mail Alert Related Categories
DowngradesRelated Entities
Needham & Company, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
